A 42-year-old woman presents with a 3-month history of symmetrical polyarthritis affecting the small joints of both hands and wrists, morning stiffness lasting 2 hours, and constitutional symptoms. Physical examination reveals swollen, tender metacarpophalangeal and proximal interphalangeal joints. ESR is 68 mm/h and CRP is 12 mg/dL. Which investigation is most specific for confirming the diagnosis of rheumatoid arthritis?

Explanation

## Diagnostic Specificity in Rheumatoid Arthritis **Key Point:** Anti-CCP antibodies are the most specific serological marker for rheumatoid arthritis, with specificity >95% and superior predictive value for erosive disease compared to RF. ### Why Anti-CCP is Superior **High-Yield:** Anti-CCP antibodies: - Present in 70–80% of RA patients - Appear early in disease (even before symptom onset) - Predict progression to erosive disease - Remain positive throughout disease course - Have specificity >95% for RA - Can be positive in seronegative RA (RF-negative) ### Comparison of Serological Markers in RA | Marker | Sensitivity | Specificity | Prognostic Value | Timing | |--------|-------------|-------------|------------------|--------| | Anti-CCP | 70–80% | >95% | Predicts erosions | Early, pre-symptom | | RF (IgM) | 70–80% | 85% | Moderate | Variable | | RF (IgG/IgA) | 50–60% | 90% | Better than IgM | Later | | ANA | 30–40% | Low in RA | Poor | Non-specific | | C3/C4 | Variable | None | Reflects activity | Non-specific | **Clinical Pearl:** A patient with clinical RA and positive anti-CCP but negative RF is classified as "seropositive RA" (anti-CCP positive) and carries similar prognosis to RF-positive disease. This distinction is crucial for early aggressive therapy. ### Diagnostic Algorithm ```mermaid flowchart TD A[Suspected RA: symmetric polyarthritis + morning stiffness]:::outcome --> B{Check RF and Anti-CCP}:::decision B -->|Both positive| C[Seropositive RA]:::outcome B -->|Anti-CCP+ / RF-| D[Anti-CCP seropositive RA]:::outcome B -->|Both negative| E[Seronegative RA<br/>Diagnose on clinical + imaging]:::outcome C --> F[High risk of erosions<br/>Early DMARD therapy]:::action D --> G[Similar prognosis to RF+<br/>Early DMARD therapy]:::action E --> H[Confirm with imaging<br/>Consider other diagnoses]:::action ``` **Mnemonic:** **ANTI-CCP = ACE** — **A**ccurate (>95% specificity), **C**linically predictive (erosions), **E**arly (pre-symptom). **Warning:** Do not rely on RF alone for diagnosis — 20–30% of RA patients are RF-negative, but many are anti-CCP positive. Seronegative RA exists and is diagnosed clinically with imaging support.